Menopausal women pose as men to buy testosterone online after prescription difficulties
Wales Menopause Crisis: Women Disguise Themselves as Men to Obtain Testosterone Online
Ninoda.com – Post-menopausal women across Wales are filling out online pharmacy questionnaires under male identities simply to secure a supply of testosterone — a workaround born from frustration with inconsistent NHS prescribing policies. The practice, confirmed by a senior sexual and reproductive health consultant, reveals a gap between clinical need and administrative reality in one of the UK's most under-resourced menopause-care landscapes.
The hormone in question is not foreign to female biology. Testosterone circulates naturally in women at modest concentrations, declining gradually with age. For those already managing menopause through standard Hormone Replacement Therapy yet still battling persistent low libido, clinicians may add a carefully dosed testosterone preparation. Because no testosterone product carries a specific licence for women anywhere in the United Kingdom, the male formulation is prescribed at substantially reduced doses, with mandatory baseline bloodwork and periodic monitoring to keep levels within the physiological female range.
A Sharp Rise in Referrals, Uneven Access
Dr Michelle Olver, a consultant in sexual and reproductive health, describes a "very sharp increase" in testosterone referrals reaching the NHS for post-menopausal women. Yet the pathway from referral to actual prescription is far from uniform. Different Welsh health boards apply different thresholds, and some GP practices simply decline to prescribe the hormone at all. The result, for women who have exhausted conventional HRT options, is a dead end in the public system — and a tempting shortcut through commercial online pharmacies that do not verify gender on their intake forms.
"We want to maintain women in female physiological range for testosterone. We don't want them to have sky-high levels. When you persistently have very high testosterone levels you can get undesirable permanent side effects. Nobody wants to have baldness, deepening of the voice or enlargement of the clitoris."
Olver reports having examined patients whose circulating testosterone reached up to twelve times the recommended safe ceiling — a consequence of unsupervised online purchases with no professional oversight. She calls the situation "incredibly sad," noting that women are effectively "denied access to something they need" and then forced to lie to obtain it. Her position is that proper counselling, informed consent, and regular blood monitoring must accompany any testosterone prescription, and that an equitable, all-Wales prescribing framework should exist so that geography does not determine whether a woman can receive a clinically indicated treatment.
The Licensing Gap and Ongoing Research
The absence of a women-specific testosterone licence in the UK means every prescription is technically an off-label use of a male product. Clinicians mitigate this by titrating doses far below those used in men and by scheduling repeat blood tests. While the evidence base for testosterone's benefit on post-menopausal libido is established, broader claims — that the hormone improves cognitive sharpness or daily energy — remain anecdotal. A study currently running in Wales aims to determine whether those subjective reports have any measurable scientific foundation, which could reshape prescribing criteria if confirmed.
Personal Accounts: Relief, Discomfort, and Bureaucratic Dead Ends
Emma Thomas, 59, of Sully in the Vale of Glamorgan, co-founded the menopause peer-support group Menopals Cardiff and Vale after years of watching members struggle to access adequate treatment. She describes her own turning point at age 47, when a previously "really sociable, happy person" became someone who felt "quite insecure, paranoid, low in mood."
"I'd sort of lost my joy."
Standard HRT, she says, produced a noticeable shift within ten days of starting. Once her oestrogen and progesterone regimen stabilised, her GP added a low-dose testosterone component. The effect, however, was slow — roughly six months before she perceived a meaningful change.
"It was the final piece of the puzzle for me. I feel like my old self — I've got a zest for life."
Thomas advocates for broader GP training so that primary-care doctors feel confident prescribing testosterone as one element of a tailored menopause plan, rather than defaulting to "there's no need for it" or simply refusing the prescription.
Not every woman experiences the same benefit. Emma Jones, 57, tried testosterone and noticed an energy lift within a week, but also felt "jittery and on edge."
"I felt like I'd changed into the body of an 18-year-old, thinking about sex from the moment I woke up,"
she recalls with a laugh. For Jones, the hormone was not the right fit, yet she insists women deserve full information and the opportunity to trial different HRT combinations so they can identify what works for their own bodies.
One woman, speaking to BBC Wales, described being prescribed testosterone by her NHS GP and then relocating to a neighbouring health-board area. Her new practice refused to continue the prescription. She paid privately for a consultation, a fresh prescription, and blood tests. Once her levels stabilised, she completed an online pharmacy questionnaire listing herself as male — securing the same hormone at a fraction of the private cost.
Government Response and Broader Implications
The Welsh government responded that "all health boards are expected to provide individualised care," a statement that stops short of mandating uniform access. Dr Rebeccah Tomlinson, a GP who runs an NHS menopause clinic, has highlighted the inconsistency between boards as a systemic problem rather than an isolated one.
The episode underscores a wider tension in menopause medicine: as evidence accumulates that testosterone can be a valuable adjunct for a subset of post-menopausal women, administrative fragmentation and the absence of a women-specific licence leave patients navigating a patchwork of local policies. Until a coherent, Wales-wide prescribing protocol exists — complete with mandatory monitoring and clear eligibility criteria — the incentive to seek the hormone through unregulated channels will persist, and the risk of permanent, unwanted side effects will remain a quiet public-health concern hidden behind a simple online form.
Related Reading
Frequently Asked Questions
What is Menopausal women pose as men to buy?Menopausal women pose as men to buy is the main topic of this guide. The article explains the context, practical details, and next steps readers should understand.
Why does Menopausal women pose as men to buy matter?Menopausal women pose as men to buy matters because readers are looking for a useful answer, not just a short summary. Good content should match search intent and help them decide what to do next.